Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
Montelukast
IMED Healthcare Ltd.
R03DC03
Montelukast
10 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
montelukast
Authorised
2012-05-11
PACKAGE LEAFLET: INFORMATION FOR THE USER SINGULAIR ® 10 MG FILM-COATED TABLETS montelukast READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Singulair is and what it is used for 2. What you need to know before you take Singulair 3. How to take Singulair 4. Possible side effects 5. How to store Singulair 6. Contents of the pack and other information 1. WHAT SINGULAIR IS AND WHAT IT IS USED FOR WHAT SINGULAIR IS Singulair is a leukotriene receptor antagonist that blocks substances called leukotrienes. HOW SINGULAIR WORKS Leukotrienes cause narrowing and swelling of airways in the lungs and also cause allergy symptoms. By blocking leukotrienes, Singulair improves asthma symptoms, helps control asthma and improves seasonal allergy symptoms (also known as hay fever or seasonal allergic rhinitis). WHEN SINGULAIR SHOULD BE USED Your doctor has prescribed Singulair to treat asthma, preventing your asthma symptoms during the day and night. • Singulair is used for the treatment of adults and adolescents 15 years of age and older who are not adequately controlled on their medication and need additional therapy. • Singulair also helps prevent the narrowing of airways triggered by exercise. • In those asthmatic patients in whom Singulair is indicated in asthma, Singulair can also provide symptomatic relief of seasonal allergic rhinitis. Your doctor will determine how Singulair should be used depending on the symptoms and severity of your asthma. WHAT IS ASTHMA? Asthma is a long-term disease. As Прочитайте повний документ
Health Products Regulatory Authority 17 July 2023 CRN00DPPN Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Singulair 10 mg film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One film-coated tablet contains montelukast sodium, which is equivalent to 10 mg montelukast. Excipient(s) with known effect: lactose monohydrate For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. _Product imported from Czech Republic and Poland:_ Beige, rounded square, film-coated with SINGULAIR engraved on one side, MSD 117 on the other. 4 CLINICAL PARTICULARS As per PA23198/014/004 5 PHARMACOLOGICAL PROPERTIES As per PA23198/014/004 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Microcrystalline cellulose Lactose monohydrate Croscarmellose sodium Hyprolose (E 463) Magnesium stearate Film coating: Hypromellose Hyprolose (E 463) Titanium dioxide (E 171) Red and yellow ferric oxide (E 172) Carnauba wax 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the blister strips and outer carton of the product on the market in the country of origin. Health Products Regulatory Authority 17 July 2023 CRN00DPPN Page 2 of 2 6.4 SPECIAL PRECAUTIONS FOR STORAGE Store below 30°C. Store in the original package in order to protect from light and moisture. 6.5 NATURE AND CONTENTS OF CONTAINER Aluminium blister strips in an over-labelled cardboard carton containing 28 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT Any unused medicinal product or waste material should be disposed of in accordance with local requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER IMED Healthcare Ltd. Unit 625 Kilshane Avenue Northwest Business Park Ballycoolin Dublin 15 Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1463/064/003 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisa Прочитайте повний документ